• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Memantine in MS: no effect on cognitive performance

September 15, 2010  

Beta-interferon in MS: effect on long-term mortality

September 1, 2010  

Mitoxantrone in MS: AAN report

August 18, 2010  

Follow-up data of rituximab in SPMS

June 23, 2010  

Twice-weekly glatiramer acetate as effective as daily dosing

June 2, 2010  

CCSVI: an update

June 2, 2010  

Beta-interferons and glatiramer acetate: data at 15 years

May 26, 2010  

Poor MS symptom control associated with unemployment

May 12, 2010  

New FDA warning for Tysabri

April 28, 2010  

Chronic cerebrospinal venous insufficiency (CCSVI)

February 16, 2010  
Previous
39
40
41
42
43
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions